LOPREEZA
- Product NDC
- 69238-1609
- Requested package NDC
- 69238-1609-6
- 11-digit product format
- 692381609
- Labeler code
- 69238
- Product ID
- 69238-1609_617a2d78-e850-4965-a23a-b0eacd0541a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- estradiol/norethindrone acetate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- NDA020907
- Marketing category
- NDA
- Marketing start
- 2019-01-07
- Substance
- ESTRADIOL; NORETHINDRONE ACETATE
- Active strength
- .5; .1 mg/1; mg/1
- Pharmacologic classes
- Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020907-001 | ACTIVELLA | ESTRADIOL; NORETHINDRONE ACETATE | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 |
| N020907-002 | ACTIVELLA | ESTRADIOL; NORETHINDRONE ACETATE | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020907-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2006-12-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG | TABLET / ORAL | RLD | 2006-12-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG | TABLET / ORAL | RLD | 2006-12-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG | TABLET / ORAL | RLD | 2006-12-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020907-001 | ACTIVELLA | 1MG;0.5MG | TABLET / ORAL | AB | RLD, RS | 1998-11-18 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020907-002 | ACTIVELLA | 0.5MG;0.1MG | TABLET / ORAL | AB | RLD | 2006-12-28 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020907-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020907-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020907-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020907-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020907-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020907-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020907-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020907-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020907-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020907-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020907-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020907-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020907-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020907-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020907-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020907-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020907-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N020907-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N020907-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N020907-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020907-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N020907-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N020907-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N020907-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020907-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020907-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N020907-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020907-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N020907-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020907-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N020907-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020907-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N020907-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020907-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N020907-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020907-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020907-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020907-002 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020907-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N020907-001 | AB | 1 | 1c564ffb4f44… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LOPREEZA
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTRADIOL | .5 mg/1 |
| NORETHINDRONE ACETATE | .1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9S44LIC7OJ | Internal UNII lookup |
| 4TI98Z838E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 966ac064-9eb7-4d15-b271-a7880ed1e79a | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-1609-6 | LOPREEZA | 28 in 1 BLISTER PACK | TABLET, FILM COATED | 28 | 10 | |
| 69238-1609-6 | LOPREEZA | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69238-1609 | LOPREEZA (ESTRADIOL/NORETHINDRONE ACETATE) TABLET, FILM COATED [AMNEAL PHARMACEUTICALS NY LLC] | 10 | Current NDC, Legacy NDC, 2 package rows | 20250124_966ac064-9eb7-4d15-b271-a7880ed1e79a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOPREEZA | ESTRADIOL/NORETHINDRONE ACETATE | Amneal Pharmaceuticals NY LLC | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 2025-01-16 | Boxed warning, Warnings, Adverse reactions | 020907 NDA020907 69238-1609-6 69238-1609 69238160906 |
| Activella | ESTRADIOL/NORETHINDRONE ACETATE | Amneal Pharmaceuticals LLC | d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0 | 2023-11-30 | Boxed warning, Warnings, Adverse reactions | 020907 NDA020907 |
| Lopreeza | ESTRADIOL/NORETHINDRONE ACETATE | Amneal Pharmaceuticals NY LLC | bf0e39cb-95e7-4831-92d2-0b3f071aeaae | 2017-11-30 | Boxed warning, Warnings, Adverse reactions | 020907 NDA020907 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1550964 | {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack [Lopreeza 0.5/0.1 28 Day] | BPCK | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1550965 | {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Lopreeza 1/0.5 28 Day] | BPCK | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359124 | {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack | GPCK | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359127 | {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack | GPCK | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359124 | Estra-Noreth Ac 0.5-0.1 MG (28) Oral Tablet 28 Day Pack | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359127 | Estra-Noreth Ac 1-0.5 MG (28) Oral Tablet 28 Day Pack | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359123 | estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359126 | estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1550964 | Lopreeza 0.5/0.1 28 Day Pack | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1550965 | Lopreeza 1/0.5 28 Day Pack | PSN | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359123 | estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet | SCD | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1359126 | estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet | SCD | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1550964 | Lopreeza 0.5/0.1 28 Day Pack | SY | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
| 1550965 | Lopreeza 1/0.5 28 Day Pack | SY | 966ac064-9eb7-4d15-b271-a7880ed1e79a | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69238-1609-6 | 69238160906 | 1 BLISTER PACK in 1 CARTON (69238-1609-6) / 28 TABLET, FILM COATED in 1 BLISTER PACK | 1 blister pack | 2019-01-07 | No | No | Current |